Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  Identification and selective inhibition of the channel mode of the neuronal GABA transporter 1

Krause, S. M., & Schwarz, W. (2005). Identification and selective inhibition of the channel mode of the neuronal GABA transporter 1. Molecular Pharmacology, 68(6), 1728-1735. doi:10.1124/mol.105.013870.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Krause, Stephan M.1, Autor           
Schwarz, Wolfgang1, Autor           
Affiliations:
1Department of Biophysical Chemistry, Max Planck Institute of Biophysics, Max Planck Society, ou_2068289              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: The function of GAT1, the transporter for the inhibitory neurotransmitter GABA, is characterized by expression in Xenopus laevis oocytes and measurements of GABA-induced uptake of [3H]GABA, 22Na+, and 36Cl-, and GABA-evoked currents under voltage-clamp conditions. N-[4,4-Diphenyl-3-butenyl]-nipecotic acid (SKF-89976-A), a specific inhibitor of GAT1, is used in our system as a pharmacological tool. The GABA-evoked current can be decomposed into a transport current, which is coupled to the GABA uptake, and a transmitter-gated current, which is uncoupled from the GABA uptake. The transport current results from a fixed stoichiometry of 1 GABA/2 Na+/1 Cl- transported during each cycle, as determined by radioactive tracer flux measurements. The transmitter-gated current is mediated by an Na+-conductance pathway. As a competitive inhibitor for GABA uptake, SKF-89976-A can separate the two current components. The GABA uptake is blocked with a KI value of approximately 7 μM, whereas the uncoupled transmitter-gated current is inhibited with a KI value of approximately 0.03 μM. Thus, the results of this study not only identify the transport mode and the channel mode of GAT1 but also raise the possibility of separating these components in a physiological environment.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2005-04-192005-09-172005-11-172005-12-01
 Publikationsstatus: Erschienen
 Seiten: 8
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: DOI: 10.1124/mol.105.013870
PMID: 16150932
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Molecular Pharmacology
  Andere : Mol. Pharmacol.
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: Bethesda, Md. : American Society for Pharmacology and Experimental Therapeutics
Seiten: - Band / Heft: 68 (6) Artikelnummer: - Start- / Endseite: 1728 - 1735 Identifikator: ISSN: 0026-895X
CoNE: https://pure.mpg.de/cone/journals/resource/954925426203